Evaluation of immunogenicity and contraceptive efficacy of gamete-specific recombinant proteins for the development of contraceptive vaccine
Shrestha, A.; Gupta, S.K.
Journal of Reproductive Immunology 101-102: 46
2014
ISSN/ISBN: 0165-0378 DOI: 10.1016/j.jri.2013.12.044Document Number: 502069
Document emailed within 0-6 h
Related Documents
Audet, M.C.; Moreau, M.; Koltun, W.D.; Waldbaum, A.S.; Shangold, G.; Fisher, A.C.; Creasy, G.W. 2001: Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial JAMA 285(18): 2347-2354Prakash, A.O. 1985: Evaluation biologique de l'efficacité de l'action contraceptive d'extraits de certaines plantes médicinales chez la femme - Biological evaluation of some medicinal plants extracts for contraceptive efficacy in females Contraception Fertilite Sexualite (1973) 13(4): 649-655
Et Al 1984: Comparative evaluation of contraceptive efficacy of norethisterone enanthate 200 milligram injectable contraceptive given every 2 or 3 months Contraception 30(6): 561-574
Et Al 1984: Comparative evaluation of contraceptive efficacy of norethisterone enanthate 200 milligram injectable contraceptive given every 2 or 3 months Contraception 30(6): 561-574
Melnick, A.L.; Rdesinski, R.E.; Creach, E.Dawn.; Choi, D.; Harvey, S.Marie. 2008: The influence of nurse home visits, including provision of 3 months of contraceptives and contraceptive counseling, on perceived barriers to contraceptive use and contraceptive use self-efficacy Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health 18(6): 471-481
Melnick, A.L.; Rdesinski, R.E.; Creach, E.Dawn.; Choi, D.; Harvey, S.Marie. 2008: The influence of nurse home visits, including provision of 3 months of contraceptives and contraceptive counseling, on perceived barriers to contraceptive use and contraceptive use self-efficacy Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health 18(6): 471-481
Levinson, R.A. 1995: Reproductive and contraceptive knowledge, contraceptive self-efficacy, and contraceptive behavior among teenage women Adolescence 30(117): 65-85
Khobarekar, B.G.; Vernekar, V.; Raghavan, V.; Kamada, M.; Maegawa, M.; Bandivdekar, A.H. 2008: Evaluation of the potential of synthetic peptides of 80 kDa human sperm antigen (80 kDaHSA) for the development of contraceptive vaccine for male Vaccine 26(29-30): 3711-3718
Luo, J.; Yang, J.; Cheng, Y.; Li, W.; Yin, T.-L.; Xu, W.-M.; Zou, Y.-J. 2012: Immunogenicity study of plasmid DNA encoding mouse cysteine-rich secretory protein-1 (mCRISP1) as a contraceptive vaccine American Journal of Reproductive Immunology 68(1): 47-55
Sandrini, M.C.; Pregliasco, F.; Mensi, C.; Giardini, G.; Lucchi, T.; Santambrogio, D.; Annoni, G.; Vergani, C. 1997: Immunogenicity and efficacy field evaluation (1994-1995 season) of influenza vaccine in a noninstitutionalized elderly population Annali di igiene: medicina preventiva e di comunita 9(5): 373-379
Ferro, V.A.; Garside, D.A. 2011: Reproductive component vaccine developments for contraceptive and non-contraceptive uses Expert Opinion on Therapeutic Patents 21(9): 1473-1482
London, R.S.; Chapdelaine, A.; Upmalis, D.; Olson, W.; Smith, J. 1992: Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive Acta Obstetricia et Gynecologica Scandinavica. Suppl 156: 9-14
Siirin, M.T.; Travassos da Rosa, A.P.A.; Newman, P.; Weeks-Levy, C.; Coller, B-Ann.; Xiao, S-Yuan.; Lieberman, M.M.; Watts, D.M. 2008: Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters American Journal of Tropical Medicine and Hygiene 79(6): 955-962
Talwar, G.P.; Gupta, J.C.; Rulli, S.B.; Sharma, R.S.; Nand, K.N.; Bandivdekar, A.H.; Atrey, N.; Singh, P. 2015: Advances in development of a contraceptive vaccine against human chorionic gonadotropin Expert Opinion on Biological Therapy 15(8): 1183-1190
Naz, R.K.; Gupta, S.K.; Gupta, J.C.; Vyas, H.K.; Talwar, A.G.P. 2005: Recent advances in contraceptive vaccine development: a mini-review Human Reproduction 20(12): 3271-3283
Chen, Y.-d.; Liang, X.-f.; Yao, J.; Cui, F.-q.; Li, Q.; Jiang, Z.-g.; Wang, F.-z.; Fang, C.-f.; Chen, R.-f.; Su, M.-f.; Zheng, X.-h. 2011: Evaluation on the efficacy of recombinant hepatitis B vaccine booster immunization in 2789 children aged over 10 years Zhonghua Liu Xing Bing Xue Za Zhi 32(3): 252-255
1988: A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection. I: Contraceptive efficacy and side effects Contraception (Stoneham) 37(1): 1-20
Kurpisz, M. 1990: Relevance of immuno-contraceptive vaccines for population control. II. Gamete antigens Archivum Immunologiae et Therapiae Experimentalis 38(1-2): 61-78
Cullberg, G.; Adelgaard, J.; Andersen, J.N.; Andersen, E.S.; Berg, H.; Bergink, E.W.; Buhl, G.; Pedersen, J.H.; Poulsen, L. 1984: Restovar--new low-dose, combined, oral contraceptive. Effects on serum proteins, free testosterone and clinical efficacy Contraceptive Delivery Systems 5(2): 97-104
Moyes, C.; Milne, A. 1988: Immunogenicity of a recombinant yeast-derived hepatitis B vaccine (Engerix B) in children New Zealand Medical Journal 101(843): 162-164